Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-140.24	-346.63	-653.69	-971.23	-796.7	-407.24
Depreciation & Amortization	51.39	51.39	131.45	120.75	44.6	32.46
Other Amortization	0.81	0.81	1.95	3.35	3.16	0.85
Loss (Gain) From Sale of Assets	2.2	2.2	1.01	1.42	0.18	0.22
Asset Writedown & Restructuring Costs	35.13	35.13	-	-	-	-
Loss (Gain) From Sale of Investments	0.25	0.25	-	-	-	-
Loss (Gain) on Equity Investments	0.09	0.09	0.36	0.29	0.48	0.28
Stock-Based Compensation	155.62	155.62	260.72	326.78	282.43	173.22
Provision & Write-off of Bad Debts	10.54	10.54	18.5	24.92	12.12	17.16
Other Operating Activities	-158.35	34.87	36.07	48.07	38.23	-2.59
Change in Accounts Receivable	-26.8	-26.8	-16.4	-42.16	-49.77	-38.16
Change in Inventory	2.51	2.51	57.28	-21.65	-67	-9.44
Change in Accounts Payable	18.89	18.89	-31.12	16.63	-5.1	25.84
Change in Unearned Revenue	-13.5	-13.5	-16.67	5.43	68.21	24.14
Change in Other Net Operating Assets	-17.63	-17.63	-45.24	30.6	-8.73	109.73
Operating Cash Flow	-79.09	-92.26	-255.78	-456.81	-477.89	-73.54
Capital Expenditures	-5.42	-5.42	-8.1	-70.29	-210.92	-75.57
Sale of Property, Plant & Equipment	1.57	1.57	0.08	2.41	0.57	0.65
Sale (Purchase) of Intangibles	-0.56	-0.56	-1.28	-0.19	-2.53	-3.97
Investment in Securities	-	-	-	65.6	294.58	-30.42
Investing Cash Flow	-3.12	-4.41	-9.3	-7.46	81.7	-109.31
Short-Term Debt Issued	-	-	-	-	-	5
Long-Term Debt Issued	-	-	-	-	-	18.21
Total Debt Issued	-	-	-	-	-	23.21
Short-Term Debt Repaid	-	-	-	-2.37	-5	-
Long-Term Debt Repaid	-	-	-	-	-39.81	-43.8
Total Debt Repaid	-	-	-	-2.37	-44.81	-43.8
Net Debt Issued (Repaid)	-	-	-	-2.37	-44.81	-20.59
Issuance of Common Stock	-	-	-	-	-	1,920
Repurchase of Common Stock	-0.07	-0.07	-6.98	-71.83	-4.27	-
Other Financing Activities	2	-	-41.86	-12.04	-3.82	-
Financing Cash Flow	1.93	-0.07	-48.83	-86.24	-52.9	2,166
Foreign Exchange Rate Adjustments	2.26	3.69	3.86	36.67	-37.01	-155.9
Net Cash Flow	-78.02	-93.05	-310.05	-513.84	-486.09	1,827
Free Cash Flow	-84.51	-97.68	-263.89	-527.1	-688.81	-149.12
Free Cash Flow Margin	-15.76%	-18.94%	-49.10%	-93.58%	-135.63%	-34.69%
Free Cash Flow Per Share	-8.01	-9.49	-25.77	-50.73	-66.10	-21.73
Cash Interest Paid	-	-	-	0.88	1.52	3.55
Cash Income Tax Paid	-	-	-	0.1	1.11	-
Levered Free Cash Flow	95.42	-7.71	-57.45	-220.17	-305.26	-21.63
Unlevered Free Cash Flow	95.42	-7.71	-57.45	-220.17	-304.3	-21.21
Change in Working Capital	-36.53	-36.53	-52.16	-11.16	-62.4	112.1

Updated Sep 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q